Barbara Stecca

17PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsHaematological tumoursCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 25, 2025
The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells.

Ignazia Tusa, Sinforosa Gagliardi, Alessio Menconi

|Aug 01, 2024
Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma.

Alessandro Giammona, Chiara De Vellis, Enrica Crivaro

|Feb 22, 2023
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma.

Giulia Anichini, Chiara Raggi, Mirella Pastore

|Jan 21, 2023
Emerging Roles of Hedgehog Signaling in Cancer Immunity.

Alessandro Giammona, Enrica Crivaro, Barbara Stecca

|Aug 18, 2022
Quinolines and Oxazino-quinoline Derivatives as Small Molecule GLI1 Inhibitors Identified by Virtual Screening.

Fabrizio Manetti, Luisa Maresca, Enrica Crivaro

|May 14, 2022
Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment.

Luisa Maresca, Barbara Stecca, Laura Carrassa

Pageof 3